0001552123-12-000001.txt : 20120613
0001552123-12-000001.hdr.sgml : 20120613
20120613121007
ACCESSION NUMBER: 0001552123-12-000001
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120611
FILED AS OF DATE: 20120613
DATE AS OF CHANGE: 20120613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tomlinson Bruce
CENTRAL INDEX KEY: 0001552123
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 12904590
MAIL ADDRESS:
STREET 1: C/O PDL BIOPHARMA, INC.
STREET 2: 932 SOUTHWOOD BOULEVARD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0205
3
2012-06-11
1
0000882104
PDL BIOPHARMA, INC.
PDLI
0001552123
Tomlinson Bruce
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BOULEVARD
INCLINE VILLAGE
NV
89451
0
1
0
0
Chief Financial Officer
/s/Danny J. Hart, Jr., Attorney-in-Fact for Bruce Tomlinson
2012-06-13
EX-24
2
brucetomlinsonpoa.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Danny J Hart, Jr. and
Christopher Stone, and each of them, his or her, true and lawful
attorney-in-fact to: (1) prepare, execute in the undersigned's name and
on the undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and any
other documents necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act of 1934 or any
rule or regulation of the SEC; (2) execute for and on behalf of the
undersigned, in the undersigned's capacity as an officer and/or director,
and/or person who holds more than 10% of the stock of PDL BioPharma; Inc.
(the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a).of the
Securities ' Exchange Act of 1934, as amended (the "Exchange Act") and the
rules thereunder; (3) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete and execute
any such Form 3, 4 or 5, complete and execute any amendment(s) thereto, and
timely file any such form with the United States Securities and' Exchange
Commission and any stock exchange or similar authority; and (4) take any
other action of any type whatsoever in connection with the foregoing which,
in the opinion of such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve
in such attorney-in-fact's discretion.The undersigned hereby grants to each
such attorney-in-fact full power and authority to do and perform any and every
act and thing whatsoever requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's
substitute or substitutes, shall lawfully do or cause to be done pursuant to
this power of attorney. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked or modified by the undersigned in a signed
writing, but shall terminate automatically as to each individual
attorney-in-fact when such person is no longer an employee of the Company.
This Power of Attorney may be filed with the SEC as a confirming statement
of the authority granted herein.
The undersigned has caused this Power of Attorney to be executed as of
this
11thhh
day of June, 2012.
By: Printed Name: Bruce Tomlinson